by Nakita | Aug 4, 2026 | Research Opportunities
Express Interest Do you have kidney disease due to lupus? Researchers at King’s College London are looking for adults with kidney disease due to lupus to take part in an online research interview exploring views on immune suppressing treatment and monitoring. ...
by Nakita | Aug 4, 2026 | Research Opportunities
Hydroxychloroquine (HCQ) is a treatment often used for autoimmune and inflammatory conditions. However, a small number of long-term users develop retinal toxicity (damage to the retinas in the eye), also known as HCQ retinopathy. This can lead to permanent sight loss....
by Nakita | Aug 4, 2026 | Research Opportunities
Would you like to take part in a study exploring your reasons for and experiences of attending A&E for help with your persistent pain? Deadline: 15th August 2026 Location: Online When: Interviews will take place during August 2026 Interested in taking part?...
by Nakita | Jun 11, 2026 | Latest News, Research Opportunities
In this article, we use “lupus” instead of “SLE” (systemic lupus erythematosus). In England and Wales, doctors can use a medicine called obinutuzumab to treat kidney disease caused by lupus. You might know this as lupus nephritis. Research has shown that obinutuzumab...
by Nakita | May 21, 2026 | Research Opportunities
BILAG Biologics Register Are you starting treatment with a biologic, biosimilar or other new therapy for your lupus? You could be eligible to join the BILAG Biologics Register (BR) and help them collect important data about the safety and effectiveness of different...
by Nakita | Feb 7, 2026 | Research Opportunities
The General Pharmaceutical Council (GPhC) The General Pharmaceutical Council (GPhC) makes sure pharmacy is safe and effective for patients and the public. They are inviting patients, carers, and members of the public to share their views on pharmacy services across...
